Suppr超能文献

抗 HIV-1 gp41 人源单克隆抗体的亲和力成熟和鉴定。

Affinity maturation and characterization of a human monoclonal antibody against HIV-1 gp41.

机构信息

Department of Biologics Research, Merck Research Laboratories, West Point, PA, USA.

出版信息

MAbs. 2009 Sep-Oct;1(5):462-74. doi: 10.4161/mabs.1.5.9214. Epub 2009 Sep 8.

Abstract

The human D5 monoclonal antibody binds to the highly conserved hydrophobic pocket on the N-terminal heptad repeat (NHR) trimer of HIV-1 gp41 and exhibits modest yet relatively broad neutralization activity. Both binding and neutralization depend on residues in the complementarity determining regions (CDRs) of the D5 IgG variable domains on heavy chain (VH) and light chain (VL). In an effort to increase neutralization activity to a wider range of HIV-1 strains, we have affinity matured the parental D5 scFv by randomizing selected residues in 5 of its 6 CDRs. The resulting scFv variants derived from four different CDR changes showed enhanced binding affinities to gp41 NHR mimetic (5-helix) which correlated to improved neutralization potencies by up to 8-fold. However, when converted to IgG1s, these D5 variants had up to a 12-fold reduction in neutralization potency over their corresponding scFvs despite their slightly enhanced in vitro binding affinities. Remarkably, D5 variant IgG1s bearing residue changes in CDRs that interact with epitope residues N-terminal to the hydrophobic pocket (such as VH CDR3 and VL CDR3) retained more neutralization potency than those containing residue changes in pocket-interacting CDRs (such as VH CDR2). These results provide compelling evidence for the existence of a steric block to an IgG that extends to the gp41 NHR hydrophobic pocket region, and can be a useful guide for developing therapeutic antibodies and vaccines circumventing this block.

摘要

人源 D5 单克隆抗体结合 HIV-1 gp41 N 端七肽重复(NHR)三聚体上高度保守的疏水性口袋,表现出适度但相对广泛的中和活性。结合和中和均依赖于 D5 IgG 重链(VH)和轻链(VL)可变区的互补决定区(CDR)中的残基。为了提高对更广泛范围的 HIV-1 株的中和活性,我们通过随机改变其 6 个 CDR 中的 5 个选定残基来对亲本 D5 scFv 进行亲和力成熟。来自四个不同 CDR 变化的 scFv 变体显示出与 gp41 NHR 模拟物(5 螺旋)更强的结合亲和力,这与高达 8 倍的改善中和效力相关。然而,当转化为 IgG1 时,这些 D5 变体的中和效力比其相应的 scFv 降低了多达 12 倍,尽管它们的体外结合亲和力略有增强。值得注意的是,在与疏水性口袋 N 端的表位残基相互作用的 CDR 中发生残基变化的 D5 变体 IgG1(如 VH CDR3 和 VL CDR3)保留了比在口袋相互作用的 CDR 中发生残基变化的 D5 变体 IgG1(如 VH CDR2)更多的中和效力。这些结果提供了令人信服的证据,证明存在一种对延伸到 gp41 NHR 疏水性口袋区域的 IgG 的空间位阻,这可以为开发绕过这种位阻的治疗性抗体和疫苗提供有用的指导。

相似文献

1
Affinity maturation and characterization of a human monoclonal antibody against HIV-1 gp41.
MAbs. 2009 Sep-Oct;1(5):462-74. doi: 10.4161/mabs.1.5.9214. Epub 2009 Sep 8.
7
Structural basis for HIV-1 neutralization by 2F5-like antibodies m66 and m66.6.
J Virol. 2014 Mar;88(5):2426-41. doi: 10.1128/JVI.02837-13. Epub 2013 Dec 11.
9
Interaction of anti-HIV type 1 antibody 2F5 with phospholipid bilayers and its relevance for the mechanism of virus neutralization.
AIDS Res Hum Retroviruses. 2011 Aug;27(8):863-76. doi: 10.1089/AID.2010.0265. Epub 2011 Jan 15.
10
Mechanism of HIV-1 neutralization by antibodies targeting a membrane-proximal region of gp41.
J Virol. 2014 Jan;88(2):1249-58. doi: 10.1128/JVI.02664-13. Epub 2013 Nov 13.

引用本文的文献

2
Gp41-targeted antibodies restore infectivity of a fusion-deficient HIV-1 envelope glycoprotein.
PLoS Pathog. 2020 May 11;16(5):e1008577. doi: 10.1371/journal.ppat.1008577. eCollection 2020 May.
4
Receptor Activation of HIV-1 Env Leads to Asymmetric Exposure of the gp41 Trimer.
PLoS Pathog. 2016 Dec 19;12(12):e1006098. doi: 10.1371/journal.ppat.1006098. eCollection 2016 Dec.
5
Dramatic potentiation of the antiviral activity of HIV antibodies by cholesterol conjugation.
J Biol Chem. 2014 Dec 12;289(50):35015-28. doi: 10.1074/jbc.M114.591826. Epub 2014 Oct 23.
6
Design and characterization of ebolavirus GP prehairpin intermediate mimics as drug targets.
Protein Sci. 2015 Apr;24(4):446-63. doi: 10.1002/pro.2578. Epub 2014 Oct 31.
9
Bioinformatics-led design of single-chain antibody molecules targeting DNA sequences for retinoblastoma.
Int J Ophthalmol. 2011;4(1):8-13. doi: 10.3980/j.issn.2222-3959.2011.01.02. Epub 2011 Feb 18.
10
Monoclonal antibody-based candidate therapeutics against HIV type 1.
AIDS Res Hum Retroviruses. 2012 May;28(5):425-34. doi: 10.1089/AID.2011.0226. Epub 2011 Sep 23.

本文引用的文献

2
Challenges in the development of an HIV-1 vaccine.
Nature. 2008 Oct 2;455(7213):613-9. doi: 10.1038/nature07352.
3
Characterization of the steric defense of the HIV-1 gp41 N-trimer region.
Protein Sci. 2008 Dec;17(12):2091-100. doi: 10.1110/ps.038273.108. Epub 2008 Sep 18.
5
Perspectives for a protective HIV-1 vaccine.
Adv Pharmacol. 2008;56:423-52. doi: 10.1016/S1054-3589(07)56014-X.
7
Automated high-throughput purification of antibody fragments to facilitate evaluation in functional and kinetic based assays.
J Immunol Methods. 2007 Apr 30;322(1-2):94-103. doi: 10.1016/j.jim.2007.02.006. Epub 2007 Mar 7.
9
Structural basis for HIV-1 neutralization by a gp41 fusion intermediate-directed antibody.
Nat Struct Mol Biol. 2006 Aug;13(8):740-7. doi: 10.1038/nsmb1127. Epub 2006 Jul 23.
10
Distribution and three-dimensional structure of AIDS virus envelope spikes.
Nature. 2006 Jun 15;441(7095):847-52. doi: 10.1038/nature04817. Epub 2006 May 24.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验